Literature DB >> 15361734

Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness.

Lindsey N Johnson1, Jin-Young Han, Samuel M Moskowitz, Jane L Burns, Xuan Qin, Janet A Englund.   

Abstract

Pandoraea is a recently classified genus primarily isolated from the sputum of cystic fibrosis patients, but its pathogenic potential is unknown. We describe a case of Pandoraea bacteremia in a 16-year-old cystic fibrosis patient associated with clinical disease, suggesting that this organism should be considered a true pathogen in susceptible patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361734     DOI: 10.1097/01.inf.0000136857.74561.3c

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  15 in total

1.  Clinical and microbiological features of a cystic fibrosis patient chronically colonized with Pandoraea sputorum identified by combining 16S rRNA sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  A Fernández-Olmos; M I Morosini; A Lamas; M García-Castillo; L García-García; R Cantón; L Máiz
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

2.  Intrinsic carbapenem-hydrolyzing oxacillinases from members of the genus Pandoraea.

Authors:  Ines Schneider; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

3.  Segregation is good for patients with cystic fibrosis.

Authors:  Steven Conway
Journal:  J R Soc Med       Date:  2008-07       Impact factor: 5.344

Review 4.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusa.

Authors:  Ines Schneider; Anne Marie Queenan; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 6.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  Misidentification of Pandoraea sputorum isolated from sputum of a patient with cystic fibrosis and review of Pandoraea species infections in transplant patients.

Authors:  Jason D Pimentel; Colin MacLeod
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

8.  Genome Sequences of Two Pandoraea pnomenusa Isolates Recovered 11 Months Apart from a Cystic Fibrosis Patient.

Authors:  Robson Ee; Mark Ambrose; James Lazenby; Paul Williams; Kok-Gan Chan; Louise Roddam
Journal:  Genome Announc       Date:  2015-02-05

9.  Pandoraea pnomenusa Isolated from an Australian Patient with Cystic Fibrosis.

Authors:  Mark Ambrose; Roslyn C Malley; Sanchia J C Warren; Sean A Beggs; Oliver F E Swallow; Belinda McEwan; David Stock; Louise F Roddam
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

10.  Epidemic spread of Pandoraea pulmonicola in a cystic fibrosis center.

Authors:  Nicolas Degand; Romain Lotte; Célia Decondé Le Butor; Christine Segonds; Michelle Thouverez; Agnès Ferroni; Christine Vallier; Laurent Mély; Jacqueline Carrère
Journal:  BMC Infect Dis       Date:  2015-12-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.